- Source type
- Meta-analysis
- Access type
- Abstract/index
- Publisher
- Critical Reviews in Food Science and Nutrition
- Indexed by
- PubMed
- Date
- 2017
- Added
- 2026-07-01
Trust profile
VV Source Trust Matrix v1.0
VV Source Trust Matrix v1.0 asks whether this source is trustworthy for the claim lane being used, not whether every possible claim from it is equally strong.
91
Government health research
- Publisher type
- Government research
- Bias profile
- Low
This source is strongest for safety and clinical outcomes and weaker for consumer context and regulatory status.
VV Source Fit Score 1.0
Fit by use case
Fit scores are role-specific. A source can be excellent for one claim lane and weak for another.
- Regulatory status
- 66/100
- Context Source
- Clinical outcomes
- 90/100
- Primary Anchor
- Mechanism
- 90/100
- Primary Anchor
- Safety
- 92/100
- Primary Anchor
- Consumer context
- 88/100
- Strong Support
- Trial discovery
- 89/100
- Strong Support
Best used for
- Research synthesis
- Public-health context
- Safety resources
Weak for
- Primary endpoint extraction when a study is available
Used in Viral Vitalism
Vegan Diets Can Be Elite or Deficient
Roles: Supporting evidence
Show section-level references
Vegetarian, vegan diets and multiple health outcomes: a systematic review with meta-analysis of observational studies
Roles: Supporting evidence
Show section-level references
Related studies
Related sources
CIRM: clinical and preclinical development awards
Canonicalized from June 30, 2026 rapid-brief batch.
- Trust score
- 91
- Publisher
- CIRM
- Access
- Official
- Usage
- 1 connection
FDA: Tregzi approval press announcement
Canonicalized from June 30, 2026 rapid-brief batch.
- Trust score
- 94
- Publisher
- FDA
- Access
- Official
- Usage
- 1 connection
Siren Biotechnology: FDA Fast Track Designation for SRN-101
Canonicalized from June 30, 2026 rapid-brief batch.
- Trust score
- 91
- Publisher
- Siren Biotechnology
- Access
- Publisher
- Usage
- 0 connections
CARsgen: Satri-cel approval announcement
Canonicalized from rapid brief first-solid-tumor-car-t-approval-stomach-cancer-china.
- Trust score
- 60
- Publisher
- CARsgen
- Access
- Publisher
- Usage
- 1 connection
Orca Bio: Phase 3 Precision-T data background
Canonicalized from June 30, 2026 rapid-brief batch.
- Trust score
- 60
- Publisher
- Orca Bio
- Access
- Publisher
- Usage
- 1 connection
Reuters: China approves CARsgen CAR-T treatment for stomach cancer
Canonicalized from rapid brief first-solid-tumor-car-t-approval-stomach-cancer-china.
- Trust score
- 60
- Publisher
- Reuters
- Access
- Publisher
- Usage
- 2 connections
